These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31418063)

  • 1. Multidrug-resistant organisms in urinary tract infections in children.
    Mahony M; McMullan B; Brown J; Kennedy SE
    Pediatr Nephrol; 2020 Sep; 35(9):1563-1573. PubMed ID: 31418063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic treatment and antimicrobial resistance in children with urinary tract infections.
    Vazouras K; Velali K; Tassiou I; Anastasiou-Katsiardani A; Athanasopoulou K; Barbouni A; Jackson C; Folgori L; Zaoutis T; Basmaci R; Hsia Y
    J Glob Antimicrob Resist; 2020 Mar; 20():4-10. PubMed ID: 31252156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and characteristics of urinary tract infections in children and adolescents.
    Hanna-Wakim RH; Ghanem ST; El Helou MW; Khafaja SA; Shaker RA; Hassan SA; Saad RK; Hedari CP; Khinkarly RW; Hajar FM; Bakhash M; El Karah D; Akel IS; Rajab MA; Khoury M; Dbaibo GS
    Front Cell Infect Microbiol; 2015; 5():45. PubMed ID: 26075187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-spectrum β-lactamase-producing bacteria caused less than 5% of urinary tract infections in a paediatric emergency centre.
    Jacmel L; Timsit S; Ferroni A; Auregan C; Angoulvant F; Chéron G
    Acta Paediatr; 2017 Jan; 106(1):142-147. PubMed ID: 27542840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended spectrum beta lactamase (ESBL) producing bacteria urinary tract infections and complex pediatric urology.
    Wragg R; Harris A; Patel M; Robb A; Chandran H; McCarthy L
    J Pediatr Surg; 2017 Feb; 52(2):286-288. PubMed ID: 27894763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired urinary tract infections due to extended-spectrum β -lactamase-producing organisms in United Arab Emirates.
    Ranjan Dash N; Albataineh MT; Alhourani N; Khoudeir AM; Ghanim M; Wasim M; Mahmoud I
    Travel Med Infect Dis; 2018; 22():46-50. PubMed ID: 29409967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
    BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.
    Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ
    J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-onset carbapenem-resistant Klebsiella pneumoniae urinary tract infections in infancy following NICU hospitalisation.
    Vergadi E; Bitsori M; Maraki S; Galanakis E
    J Pediatr Urol; 2017 Oct; 13(5):495.e1-495.e6. PubMed ID: 28341427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
    Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
    Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased community-acquired upper urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in children and the efficacy of flomoxef and cefmetazole.
    Horie A; Nariai A; Katou F; Abe Y; Saito Y; Koike D; Hirade T; Ito T; Wakuri M; Fukuma A
    Clin Exp Nephrol; 2019 Nov; 23(11):1306-1314. PubMed ID: 31428892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
    Akram M; Shahid M; Khan AU
    Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
    Raja NS
    J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria.
    Dewar S; Reed LC; Koerner RJ
    J Antimicrob Chemother; 2014 Feb; 69(2):303-8. PubMed ID: 24068280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary tract infections caused by Pseudomonas aeruginosa among children in Southern Poland: Virulence factors and antibiotic resistance.
    Pobiega M; Maciag J; Pomorska-Wesolowska M; Chmielarczyk A; Romaniszyn D; Ziolkowski G; Heczko PB; Wojkowska-Mach J; Bulanda M
    J Pediatr Urol; 2016 Feb; 12(1):36.e1-6. PubMed ID: 26320394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.
    Hyun HS; Kim JH; Cho MH; Park E; Ha IS; Cheong HI; Kang HG
    Pediatr Nephrol; 2019 Nov; 34(11):2399-2407. PubMed ID: 31270617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
    Bader MS; Loeb M; Leto D; Brooks AA
    Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.